Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer

BACKGROUND: Early detection of treatment failure may improve clinical outcome and overall survival in patients with head and neck cancer after first-line treatment. Circulating cell-free HPV16 DNA (cfHPV16 DNA) was evaluated as a possible complementary marker to radiological assessment of early resp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Rutkowski, Tomasz W., Mazurek, Agnieszka M., Śnietura, Mirosław, Hejduk, Beata, Jędrzejewska, Maja, Bobek-Billewicz, Barbara, d’Amico, Andrea, Pigłowski, Wojciech, Wygoda, Andrzej, Składowski, Krzysztof, Kołosza, Zofia, Widłak, Piotr
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158033/
https://ncbi.nlm.nih.gov/pubmed/32293457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02330-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars